IR@PKUHSC  > 北京大学临床肿瘤学院  > 胸部肿瘤内科
学科主题临床医学
EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer
Wang, Zhijie1; Zhang, Xuchao2; Bai, Hua1; Zhao, Jun1; Zhuo, Minglei1; An, Tongtong1; Duan, Jianchun1; Yang, Lu1; Wu, Meina1; Wang, Shuhang1; Wang, Yuyan1; Wu, Yilong2; Wang, Jie1
关键词Anaplastic lymphoma kinase EML4-ALK Echinoderm microtubule-associated protein-like 4 Epidermal growth factor receptor Non-small cell lung cancer Tyrosine kinase inhibitors
刊名ONCOLOGY
2012
DOI10.1159/000341381
83期:5页:248-256
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
资助者National Science Fund for Distinguished Young Scholars of China ; National Science Fund for Young Scholars of China ; National Science Fund for Distinguished Young Scholars of China ; National Science Fund for Young Scholars of China
研究领域[WOS]Oncology
关键词[WOS]INFLAMMATORY MYOFIBROBLASTIC TUMORS ; FUSION GENE ; PLASMA DNA ; LYMPHOMA ; EGFR ; ALK ; MUTATIONS ; GEFITINIB ; ADENOCARCINOMA ; INHIBITOR
英文摘要

Objective: To identify the clinicopathological characteristics and clinical outcomes of Chinese patients with non-small cell lung cancer (NSCLC) and to investigate possible associations of NSCLC with echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR) mutations. Methods: Patients with stage IV NSCLC were screened for EML4-ALK rearrangement and EGFR mutations at the Peking University Cancer Hospital. EML4-ALK was identified using fluorescent in situ hybridization and confirmed by immunohistochemistry. EGFR mutations were determined using denaturing high-performance liquid chromatography. Results: The incidence of EML4-ALK was 9.7% (11/113). Patients with EML4-ALK were more likely to present the EGFR wild type (WT; p = 0.033). Response to EGFR-tyrosine kinase inhibitor (TKI) was similar between patients with EML4-ALK rearrangement and EGFR mutation (33.3 vs. 46.9%, p = 0.451), but progression-free survival (PFS) was inferior compared to those with EGFR mutation (2.1 vs. 8.8 months, p = 0.032), and similar to patients with WT/nonrearrangement (2.1 vs. 2.2 months, p = 0.696; and general p = 0.023 between the three cohorts). Moreover, 2 patients with concurrent EML4-ALK and EGFR mutations had superior PFS after EGFR-TKI compared to patients with single EML4-ALK rearrangement. Conclusions: Patients with EML4-ALK conferred similar objective response rates after EGFR-TKI although inferior PFS compared to those with EGFR mutation. Coexistence of EML4-ALK and EGFR mutation might represent a separate NSCLC genotype. Copyright (C) 2012 S. Karger AG, Basel

语种英语
所属项目编号81025012 ; 81101778
资助者National Science Fund for Distinguished Young Scholars of China ; National Science Fund for Young Scholars of China ; National Science Fund for Distinguished Young Scholars of China ; National Science Fund for Young Scholars of China
WOS记录号WOS:000308741800002
引用统计
被引频次:25[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/61108
专题北京大学临床肿瘤学院_胸部肿瘤内科
作者单位1.Peking Univ, Canc Hosp & Inst, Dept Thorac Med Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China
2.Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Lung Canc Inst, Med Res Ctr, Guangzhou, Guangdong, Peoples R China
推荐引用方式
GB/T 7714
Wang, Zhijie,Zhang, Xuchao,Bai, Hua,et al. EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer[J]. ONCOLOGY,2012,83(5):248-256.
APA Wang, Zhijie.,Zhang, Xuchao.,Bai, Hua.,Zhao, Jun.,Zhuo, Minglei.,...&Wang, Jie.(2012).EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer.ONCOLOGY,83(5),248-256.
MLA Wang, Zhijie,et al."EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer".ONCOLOGY 83.5(2012):248-256.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wang, Zhijie]的文章
[Zhang, Xuchao]的文章
[Bai, Hua]的文章
百度学术
百度学术中相似的文章
[Wang, Zhijie]的文章
[Zhang, Xuchao]的文章
[Bai, Hua]的文章
必应学术
必应学术中相似的文章
[Wang, Zhijie]的文章
[Zhang, Xuchao]的文章
[Bai, Hua]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。